SCM

Sterling Capital Management Portfolio holdings

AUM $6.83B
1-Year Est. Return 19.78%
This Quarter Est. Return
1 Year Est. Return
+19.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.04B
AUM Growth
+$592M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,464
New
Increased
Reduced
Closed

Top Buys

1
+$77.4M
2
+$72.3M
3
+$54M
4
WM icon
Waste Management
WM
+$49.6M
5
AFL icon
Aflac
AFL
+$48.4M

Top Sells

1
+$77.1M
2
+$65.3M
3
+$56.9M
4
CVX icon
Chevron
CVX
+$53.1M
5
ELV icon
Elevance Health
ELV
+$44.5M

Sector Composition

1 Technology 25.19%
2 Financials 17.95%
3 Industrials 12.19%
4 Healthcare 9.59%
5 Consumer Discretionary 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENFN
3326
DELISTED
Enfusion, Inc.
ENFN
– –
-50
FFNW
3327
DELISTED
First Financial Northwest, Inc
FFNW
– –
-121
FNA
3328
DELISTED
Paragon 28, Inc.
FNA
– –
-49
PDCO
3329
DELISTED
Patterson Companies, Inc.
PDCO
– –
-1,124
AMPS
3330
DELISTED
Altus Power
AMPS
– –
-1,309
PYCR
3331
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-4,158
ATSG
3332
DELISTED
Air Transport Services Group
ATSG
– –
-884
ACCD
3333
DELISTED
Accolade Inc
ACCD
– –
-882
LGTY
3334
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
– –
-542
ITCI
3335
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-345
PTVE
3336
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
– –
-622
MDRX
3337
DELISTED
Veradigm Inc. Common Stock
MDRX
– –
-33,280
VCSA
3338
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
– –
-164
ABOS icon
3339
Acumen Pharmaceuticals
ABOS
$121M
– –
-685
ACHV icon
3340
Achieve Life Sciences
ACHV
$250M
– –
-255
ACRV icon
3341
Acrivon Therapeutics
ACRV
$77M
– –
-198
ADVM
3342
DELISTED
Adverum Biotechnologies
ADVM
– –
-374
AGEN
3343
Agenus
AGEN
$106M
– –
-354
AKA icon
3344
a.k.a. Brands
AKA
$119M
– –
-11
AKYA
3345
DELISTED
Akoya BioSciences
AKYA
– –
-26
ALXO icon
3346
ALX Oncology
ALXO
$64.5M
– –
-34
AMPY icon
3347
Amplify Energy
AMPY
$187M
– –
-677
AMTX icon
3348
Aemetis
AMTX
$93.8M
– –
-651
APLT icon
3349
Applied Therapeutics
APLT
$14M
– –
-726
ATH.PRC
3350
DELISTED
Athene Holding Ltd Series C
ATH.PRC
– –
-15,000
132 133
134
135 136